GRM2 and schizophrenia: The continuing dissection of the molecular phenotype of mGluR2−/− and mGluR3−/− mice will contribute to the understanding of the relative contribution of each receptor in the aetiopathogenesis and pharmacotherapy of schizophrenia and other psychiatric disorders in which they are increasingly implicated.